Conservative or liberal oxygen therapy for mechanically ventilated adults with acute brain pathologies: A post-hoc subgroup analysis.

Hyperoxia Hypoxia Oxygen therapy Stroke Subarachnoid hemorrhage Traumatic brain injury

Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
10 2022
Historique:
received: 19 09 2021
revised: 10 04 2022
accepted: 23 05 2022
pubmed: 7 6 2022
medline: 3 9 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

To compare the effect of conservative vs. liberal oxygen therapy in mechanically ventilated adults in the intensive care unit (ICU) with non-hypoxic ischemic encephalopathy (HIE) acute brain pathologies. Post-hoc analysis of data from 217 patients with non-HIE acute brain pathologies included in the ICU Randomized Trial Comparing Two Approaches to OXygen therapy (ICU-ROX). Patients allocated to conservative oxygen spent less time with oxygen saturation ≥ 97% (50.5 [interquartile range (IQR), 18.5-119] vs. 82 h [IQR, 38-164], absolute difference, -31.5 h; 95%CI, -59.6 to -3.4). At 180 days, 38 of 110 conservative oxygen patients (34.5%) and 28 of 104 liberal oxygen patients (26.9%) had died (absolute difference, 7.6 percentage points; 95%CI, -4.7 to 19.9 percentage points; P = 0.23; interaction P = 0.02 for non-HIE acute brain pathologies vs. HIE; interaction P = 0.53 for non-HIE acute brain pathologies vs. non-neurological conditions). In this post-hoc analysis, patients admitted to the ICU with non-HIE acute brain pathologies treated with conservative oxygen therapy did not have significantly lower mortality than those treated with liberal oxygen. A trial with adequate statistical power is needed to determine whether our day 180 mortality point estimate of treatment effect favoring liberal oxygen therapy indicates a true effect.

Identifiants

pubmed: 35660843
pii: S0883-9441(22)00108-3
doi: 10.1016/j.jcrc.2022.154079
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Banques de données

ANZCTR
['ACTRN12615000957594']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154079

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Paul J Young (PJ)

Medical Research Institute of New Zealand, Wellington, New Zealand; Intensive Care Unit, Wellington Hospital, Wellington, New Zealand; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia. Electronic address: paul.young@ccdhb.org.nz.

Diane Mackle (D)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Carol Hodgson (C)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Rinaldo Bellomo (R)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia; Intensive Care Unit, Austin Hospital, Heidelberg, Victoria, Australia; Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Michael Bailey (M)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; Intensive Care Unit, Austin Hospital, Heidelberg, Victoria, Australia.

Richard Beasley (R)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Adam M Deane (AM)

Intensive Care Unit, Austin Hospital, Heidelberg, Victoria, Australia; Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Glenn Eastwood (G)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; University of Melbourne, Parkville, Victoria, Australia.

Simon Finfer (S)

Critical Care Division and Trauma, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; School of Public Health, Imperial College London, London, England, UK.

Ross Freebairn (R)

Intensive Care Unit, Hawkes Bay Hospital, Hastings, New Zealand.

Victoria King (V)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Natalie Linke (N)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Edward Litton (E)

Intensive Care Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.

Colin McArthur (C)

Medical Research Institute of New Zealand, Wellington, New Zealand; Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand.

Shay McGuinness (S)

Medical Research Institute of New Zealand, Wellington, New Zealand; Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.

Rakshit Panwar (R)

Intensive Care Unit, John Hunter Hospital, New Lambton Heights, New South Wales, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH